WaferGen Biosystems Inc - Strategic SWOT Analysis Review

July 2017 | 35 pages | ID: WB490EB5704EN
GlobalData

Abstracts

WaferGen Biosystems Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – GlobalData’s summarization of the company’s business strategy.
• SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
• Key manufacturing facilities – A list of key manufacturing facilities of the company.

Highlights

WaferGen Biosystems Inc (WaferGen) is a biotechnology Company which develops, manufactures and sells systems for genomic technology solutions for single-cell analysis and clinical research. The Company’s ICELL8 Single-Cell System platform isolates single cells and process specific cells for analysis, including Next Generation Sequencing (NGS). The Company’s SmartChip platform is used for profiling and validating molecular biomarkers, and also performs singleplex PCR for one-step target and preparation for clinical NGS. Its Apollo 324 system processes DNA and RNA from clinical samples to NGS-ready libraries. The company’s technologies serve pharmaceutical and life science companies as well as clinical laboratories. WaferGen is the subsidiary of Takara Bio USA Holdings, Inc., and is headquartered in Fremont, California, the US.

WaferGen Biosystems Inc Key Recent Developments

Feb 15,2017: WaferGen Bio-systems Reports Revenue Growth in Fourth Quarter of 2016
Dec 15,2016: WaferGen Bio-systems Regains Compliance with Nasdaq Listing Requirements
Nov 08,2016: WaferGen Bio-systems Reports Results for Third Quarter 2016
Oct 31,2016: WaferGen Bio-systems Reports Strong Revenue Growth in Third Quarter of 2016
Aug 09,2016: WaferGen Bio-systems Reports Results for Second Quarter 2016

Reasons to Buy

• Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
• Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
• Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
• Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

Contents

SECTION 1 - ABOUT THE COMPANY

WaferGen Biosystems Inc - Key Facts
WaferGen Biosystems Inc - Key Employees
WaferGen Biosystems Inc - Key Employee Biographies
WaferGen Biosystems Inc - Major Products and Services
WaferGen Biosystems Inc - History
WaferGen Biosystems Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

WaferGen Biosystems Inc - Business Description
WaferGen Biosystems Inc - SWOT Analysis
SWOT Analysis - Overview
WaferGen Biosystems Inc - Strengths
WaferGen Biosystems Inc - Weaknesses
WaferGen Biosystems Inc - Opportunities
WaferGen Biosystems Inc - Threats
WaferGen Biosystems Inc - Key Competitors

SECTION 3 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

WaferGen Biosystems Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017
WaferGen Biosystems Inc, Medical Equipment, Deals By Type, 2011 to YTD 2017
WaferGen Biosystems Inc, Recent Deals Summary

SECTION 4 – COMPANY’S RECENT DEVELOPMENTS

Feb 15, 2017: WaferGen Bio-systems Reports Revenue Growth in Fourth Quarter of 2016
Dec 15, 2016: WaferGen Bio-systems Regains Compliance with Nasdaq Listing Requirements
Nov 08, 2016: WaferGen Bio-systems Reports Results for Third Quarter 2016
Oct 31, 2016: WaferGen Bio-systems Reports Strong Revenue Growth in Third Quarter of 2016
Aug 09, 2016: WaferGen Bio-systems Reports Results for Second Quarter 2016
Jun 16, 2016: WaferGen Receives Notice of US Patent Allowance for SmartChip and ICELL8 Single-Cell Methods and Systems to Process Genetic Material from Multi-well Arrays
Jun 06, 2016: WaferGen Bio-systems and Takara Bio Announce Exclusive Distribution Agreement for Japan
May 10, 2016: WaferGen Bio-systems Reports Results for First Quarter 2016
Mar 08, 2016: WaferGen Bio-systems Reports Results for Fourth Quarter and Fiscal Year 2015
Mar 03, 2016: WaferGen Bio-systems Announces Placement of ICELL8 Single-Cell System at Neural Stem Cell Institute

SECTION 5 – APPENDIX

Methodology
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

WaferGen Biosystems Inc, Key Facts
WaferGen Biosystems Inc, Key Employees
WaferGen Biosystems Inc, Key Employee Biographies
WaferGen Biosystems Inc, Major Products and Services
WaferGen Biosystems Inc, History
WaferGen Biosystems Inc, Subsidiaries
WaferGen Biosystems Inc, Key Competitors
WaferGen Biosystems Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017
WaferGen Biosystems Inc, Medical Equipment, Deals By Type, 2011 to YTD 2017
WaferGen Biosystems Inc, Recent Deals Summary

List Of Figures

LIST OF FIGURES

WaferGen Biosystems Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017
WaferGen Biosystems Inc, Medical Equipment, Deals by Type, 2011 to YTD 2017

COMPANIES MENTIONED

RainDance Technologies Inc
Pacific Biosciences of California, Inc.
NanoString Technologies Inc
Life Technologies Corp
GE Healthcare LLC
Fluidigm Corp
Eppendorf AG
Cepheid
Beckman Coulter Inc